Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
No Data
CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to Note
Yahoo Finance17:50 ET
EDIT, CLNE and NIU Are Among After Hour Movers
Seeking Alpha17:00 ET
Bluebird Bio Faces Nasdaq Compliance Challenge and Delays
TipRanks16:23 ET
Express News | Bluebird bio Announces Receipt of Expected Notice From Nasdaq
Reuters16:05 ET
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs
Vertex Pharmaceuticals Inc's (NASDAQ:VRTX) blockbuster drug Trikafta for cystic fibrosis (CF) has shown remarkable efficacy, potentially extending the lives of some patients by up to 45 years. Despite
Benzinga14:34 ET
Express News | HC Wainwright & Co. Reiterates Buy on Apellis Pharmaceuticals, Maintains $92 Price Target
Benzinga14:22 ET